PBM — Psyence Biomedical Share News
0.000.00%
Explainer: As Trump backs psychedelics research, FDA weighs safety and access standards
NASDAQ RESUMED AT 01:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:58 PM
Explainer: What to know about psychedelic therapies cited by Trump
NASDAQ RESUMED AT 03:11 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:06 PM
NASDAQ RESUMED AT 01:23 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:13 PM
NASDAQ RESUMED AT 12:48 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:43 PM
NASDAQ RESUMED AT 12:30 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:20 PM
NASDAQ RESUMED AT 12:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:06 PM
NASDAQ RESUMED AT 12:02 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:50 AM
Brief: Psyence Biomed Announces Export Of Gmp-Manufactured Natural Psilocybin (Npx-5) To Australia For Ongoing Phase Iib Clinical Trial
U.S. STOCKS ON THE MOVE-Micron, McDonald's, Generac
U.S. STOCKS ON THE MOVE-Klaviyo, Frontier Group, Wabtec